Thus RIP2's CARD tyrosine phosphorylation may represent a new therapeutic target to promote the survival of human lung epithelial cells in disorders that lead to acute lung injury and ARDS. The gene discussed is RIPK2; the disease is acute respiratory distress syndrome.